Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
grade A 31.89 8.73% 2.56
BHC closed up 8.73 percent on Thursday, December 12, 2019, on 3.16 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
See historical BHC trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
New 52 Week Closing High Bullish 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
New 52 Week High Strength 0.00%
Multiple of Ten Bullish Other 0.00%
BB Squeeze Ended Range Expansion 0.00%
Above Upper BB Strength 0.00%
Older signals for BHC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
Biotechnology Life Sciences Laser Organ Systems S&P/Tsx 60 Index Psoriasis Medical Devices Acne Specialty Drugs Ulcerative Colitis Atopic Dermatitis Diarrhea Irritable Bowel Syndrome Generic Pharmaceuticals Hair Removal Over The Counter Products Salix Pharmaceuticals Bausch Health Eye Health Products

Is BHC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 31.97
52 Week Low 17.2
Average Volume 4,182,866
200-Day Moving Average 23.88
50-Day Moving Average 25.34
20-Day Moving Average 28.56
10-Day Moving Average 29.15
Average True Range 0.75
ADX 45.74
+DI 49.35
-DI 9.71
Chandelier Exit (Long, 3 ATRs ) 29.71
Chandelier Exit (Short, 3 ATRs ) 28.79
Upper Bollinger Band 30.44
Lower Bollinger Band 26.68
Percent B (%b) 1.39
BandWidth 13.13
MACD Line 1.22
MACD Signal Line 1.13
MACD Histogram 0.0921
Fundamentals Value
Market Cap 11.12 Billion
Num Shares 349 Million
EPS -3.27
Price-to-Earnings (P/E) Ratio -9.75
Price-to-Sales 0.44
Price-to-Book 1.03
PEG Ratio -0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.36
Resistance 3 (R3) 35.00 33.48 34.78
Resistance 2 (R2) 33.48 32.60 33.66 34.58
Resistance 1 (R1) 32.69 32.06 33.09 33.05 34.39
Pivot Point 31.17 31.17 31.37 31.35 31.17
Support 1 (S1) 30.38 30.29 30.78 30.74 29.39
Support 2 (S2) 28.86 29.75 29.04 29.20
Support 3 (S3) 28.07 28.86 29.00
Support 4 (S4) 28.43